Incidental finding of antiphospholipid antibody syndrome in a patient with Cor Pulmonale: A case report Authors Izzah Nayyab Department of Medicine, Jinnah Hospital, Lahore, Pakistan Hassan Bashir Department of Medicine, Jinnah Hospital, Lahore, Pakistan Hamza Shahbaz Department of Pulmonology, Jinnah Hospital, Lahore, Pakistan DOI: https://doi.org/10.47391/JPMA.11079 Keywords: Antiphospholipid, Pulmonary hypertension, Cor pulmonale, Thrombosis Abstract Antiphospholipid antibody syndrome (APS), despite being an uncommon condition, displays a remarkably varied array of clinical presentations. It is a hypercoagulable disease characterised by recurrent thrombotic vascular events such as deep vein thrombosis (DVT) and pulmonary embolism. There is significant pregnancy morbidity associated with APS. Recurrent foetal loss is one of the predominant forms of presentation in women. The Sapporo classification states that there must be both clinical and laboratory findings to confirm APS. Anti-thrombotic therapy remains the mainstay of treatment. Pulmonary hypertension and right heart failure are rare complications in APS. We present the case of a 46-year-old lady diagnosed with APS and developed these rare complications. The case highlights the importance of considering APS in cases of atypical presentation with pulmonary hypertension and prior pulmonary embolism. Keywords: Antiphospholipid, Pulmonary hypertension, Cor pulmonale, Thrombosis. Downloads Full Text Article Published 2025-08-25 How to Cite Nayyab, I., Bashir, H., & Shahbaz, H. (2025). Incidental finding of antiphospholipid antibody syndrome in a patient with Cor Pulmonale: A case report. Journal of the Pakistan Medical Association, 75(09), 1453–1455. https://doi.org/10.47391/JPMA.11079 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Download Citation Endnote/Zotero/Mendeley (RIS) BibTeX Issue Vol. 75 No. 09 (2025): SEPTEMBER Section CASE REPORT License Copyright (c) 2025 Journal of the Pakistan Medical Association This work is licensed under a Creative Commons Attribution 4.0 International License.